BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37238998)

  • 1. A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial Cancers.
    Sulaiman R; De P; Aske JC; Lin X; Dale A; Gaster K; Espaillat LR; Starks D; Dey N
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancers.
    Sulaiman R; Koirala N; Aske JC; Lin X; Rojas-Espaillat L; Starks D; Dale A; Gaster K; De P; Dey N
    Am J Cancer Res; 2024; 14(2):467-489. PubMed ID: 38455423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs.
    Sulaiman R; De P; Aske JC; Lin X; Dale A; Gaster K; Espaillat LR; Starks D; Dey N
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers.
    Sulaiman R; De P; Aske JC; Lin X; Dale A; Koirala N; Gaster K; Espaillat LR; Starks D; Dey N
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
    Pradip D; Jennifer A; Nandini D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers.
    Sulaiman R; De P; Aske JC; Lin X; Dale A; Koirala N; Gaster K; Espaillat LR; Starks D; Dey N
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance.
    De P; Aske J; Sulaiman R; Dey N
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
    Ries A; Flehberger D; Slany A; Pirker C; Mader JC; Mohr T; Schelch K; Sinn K; Mosleh B; Hoda MA; Dome B; Dolznig H; Krupitza G; Müllauer L; Gerner C; Berger W; Grusch M
    J Exp Clin Cancer Res; 2023 Jan; 42(1):27. PubMed ID: 36683050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-matched and unmatched cancer associated fibroblasts exhibit differential effect on proliferation and FMOD and MMP9 gene expression in head and neck squamous cell carcinoma cells when cocultured in spheroids.
    Rademaekers M; Johansson EO; Johansson E; Roberg K; Wiechec E
    Cancer Cell Int; 2024 May; 24(1):190. PubMed ID: 38822309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts as cellular vehicles in endometrial cancer cell migration.
    Voon YC; Omar IS; Wu MH; Said NABM; Chung I
    Oncol Lett; 2022 Jan; 23(1):3. PubMed ID: 34820002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
    Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
    J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro.
    Miyazaki Y; Oda T; Mori N; Kida YS
    FEBS Open Bio; 2020 Nov; 10(11):2268-2281. PubMed ID: 32931156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
    Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
    Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
    J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer.
    Muchlińska A; Nagel A; Popęda M; Szade J; Niemira M; Zieliński J; Skokowski J; Bednarz-Knoll N; Żaczek AJ
    Cell Mol Biol Lett; 2022 Jun; 27(1):45. PubMed ID: 35690734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
    Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
    Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer.
    Katsube R; Noma K; Ohara T; Nishiwaki N; Kobayashi T; Komoto S; Sato H; Kashima H; Kato T; Kikuchi S; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
    Sci Rep; 2021 Jan; 11(1):1693. PubMed ID: 33462372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
    Huang WC; Yadav VK; Cheng WH; Wang CH; Hsieh MS; Huang TY; Lin SF; Yeh CT; Kuo KT
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.